Da ilgiornaleditalia.it: Nagase Viita to Launch Injectable-grade Pharmaceutical Excipient "SUCROSE SG" in 2025 - Il Giornale d'ItaliaOKAYAMA, Japan, Nov. 19, 2024 /PRNewswire/ -- Nagase Viita Co., Ltd., a member of the NAGASE Group headquartered in Okayama Japan, is set to expand the line of SOLBIOTE (TM), saccharide-based pharmaceutical excipients, with the launch of high-purity and l
ilgiornaleditalia.it